Home
>
US Stocks
>
Kronos Bio Inc
Kronos Bio Inc
KRON

Kronos Bio Inc

$16.4517.63%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
16.56
Today Low/High
16.43 / 17.44
52 Week Low/High
$18.81 / $39.6
Market Cap
$1.1B

Company Details

Kronos Bio is a clinical-stage biopharmaceutical company dedicated to discovering and developing therapies that seek to transform the lives of those affected by cancer. The company focuses on targeting dysregulated transcription factors and the regulatory networks within cells that drive cancerous growth. Kronos Bio’s lead investigational therapy is entospletinib, a selective inhibitor targeting spleen tyrosine kinase (SYK) in development for the frontline treatment of NPM1-mutated acute myeloid leukemia (AML). The company is also developing KB-0742, an oral inhibitor of cyclin dependent kinase 9 (CDK9), for the treatment of MYC-amplified solid tumors.
Organisation
Kronos Bio Inc
Employees
63
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Kronos Bio Inc share price today

Can Indians buy Kronos Bio Inc shares?

How can I buy Kronos Bio Inc shares from India?

Can Fractional shares of Kronos Bio Inc be purchased?

What are the documents required to start investing in Kronos Bio Inc stocks?

We are a SEBI registered investement advisor